Power3 Medical Products, Inc. (PWRM)
Breast cancer is a disease that causes the cells inside of your breast to grow too rapidly. Typically, breast cells grow in controlled cycles; this prevents too many cells from forming at any one time. Sometimes, however, these cycles break down, and cell growth becomes chaotic. As a result, masses of cells begin to form in your breast tissue, developing into cancerous tumors. Breast cancer can be invasive or non-invasive. Invasive breast cancer is much more serious, as these cancer cells can travel to different areas of your body, including your vital organs. Non-invasive breast cancer only affects the breast or surrounding breast tissue. There seem to be many factors that contribute to the development of breast cancer, ranging from hormone levels to weight. However, the main factor involved in breast cancer appears to be genetics.
Power3 Medical Products, Inc. is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig’s disease). Power3 Medical applies proprietary methodologies to discover and identify protein biomarkers associated with diseases.
BC-SeraPro� of Power3 Medical Products, Inc is a proteomic test for the diagnosis of breast cancer. This test is designed to measure the quantitative expression level of 22 protein biomarkers in the serum that differentiate between breast cancer patients and control subjects. The level of the biomarkers from the patient’s serum sample is compared to the Power3 Medical Products’ patient database. Statistical analysis by linear discriminant function will analyze the biomarker levels of the patient sample and assign a probability score for the diagnosis of the patient sample. Probability score is ranged from 0.0 to 1.0. Results of the BC-SeraPro� test should not be considered a standalone diagnosis nor a guarantee and is intended to be used in conjunction with mammography and other accepted modalities.
For more information about Power3 Medical Products, Inc. visit its website http://www.power3medical.com
Family Dollar Stores Inc. (NYSE:FDO) reported that net sales for the second quarter ended February 26, 2011, increased 8.3% to $2.26 billion from $2.09 billion in the second quarter ended February 27, 2010. Comparable store sales for the quarter increased 5.1%. Although January sales were negatively impacted by winter storms, February sales benefited from early spring-like weather. Sales during the quarter were strongest in the Consumable and Seasonal categories. The Company had 6,888 stores as of February 26, 2011, including 61 new stores opened in the second quarter.
Family Dollar Stores, Inc. operates a chain of self-service retail discount stores primarily for low and middle income consumers in the United States. The company offers consumables, including household chemicals, paper products, candy and snack products, health and beauty aids, hardware and automotive supplies, and pet food products and supplies; and home products, which comprise domestics, housewares, giftware products, and home decor products.
Darden Restaurants, Inc. (NYSE:DRI) will host its Fiscal 2011 Third Quarter conference call on Friday, March 25, 2011 at 8:30 am ET. The conference call will be broadcast live over the Internet. Clarence Otis, Chairman & CEO, and other senior management invite you to listen to a discussion of third quarter results. The subjects to be covered may also include forward-looking information, such as the outlook for the current month or quarter, and the company’s previously-announced earnings guidance. Questions may be poised to management by participants on the call and in response the company may disclose additional material information.
Darden Restaurants, Inc., through its subsidiaries, engages in the ownership and operation of full-service restaurants primarily in the United States and Canada.
Dun & Bradstreet Corp. (NYSE:DNB) has introduced an easy and affordable way for small and midsized organizations to analyze customer payment habits, protect cash flow and allocate resources for long term company growth. Part of the DNBi credit management product portfolio, DNBi Professional gives financial decision-makers a simplified tool to take advantage of D&B’s trusted insight on more than 190 million businesses worldwide.
The Dun & Bradstreet Corporation provides commercial information and insight on businesses worldwide. The company offers risk management solutions, including DNBi, an interactive online application offering the customers real time access to global business information, and monitoring and portfolio analysis; Business Information Report, Comprehensive Report, and International Report, which provide profiles of a company.
No comments:
Post a Comment